Literature DB >> 10603037

Changes in serotonergic neurons in the brain of pyrithiamine-induced acute thiamine-deficient mice.

H Matsushita1, Y Takeuchi, K Kosaka, S Fushiki, M Kawata, T Sawada.   

Abstract

We examined changes in 5-hydroxytriptamine (5-HT, serotonin) neurons in pyrithiamine-induced thiamine deficiency in mice immunohistochemically. Extensive decreases in the densities of 5-HT-immunoreactive fibers were detected in the lateral septal nucleus, the thalamus, the medial mammillary nucleus, the dorsal and the median raphe nuclei, the raphe obscurus nucleus, the tegmental area, the cerebellum and the vestibular nucleus, though only a small decrease was detected in the inferior colliculus. Most remarkably, degenerative winding fibers were detected between the deep mesencephalic nucleus and the ventral tegmental area. Increases in intensity of 5-HT immunoreactivity in the dorsal raphe nucleus and decreases in the number of 5-HT-immunoreactive cell bodies in the dorsal and the median raphe nuclei were detected. These results demonstrated the differential vulnerability of 5-HT neurons in thiamine-deficient mice. This is the first report to demonstrate changes in 5-HT neurons immunohistochemically throughout the brain of pyrithiamine-induced thiamine deficient mouse.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10603037     DOI: 10.1007/s004010051126

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  2 in total

1.  Enhanced head-twitch response to 5-HT-related agonists in thiamine-deficient mice.

Authors:  O Nakagawasai; A Murata; Y Arai; A Ohba; K Wakui; S Mitazaki; F Niijima; K Tan-No; T Tadano
Journal:  J Neural Transm (Vienna)       Date:  2007-03-20       Impact factor: 3.575

Review 2.  Brain and behavioral pathology in an animal model of Wernicke's encephalopathy and Wernicke-Korsakoff Syndrome.

Authors:  Ryan P Vetreno; Raddy L Ramos; Steven Anzalone; Lisa M Savage
Journal:  Brain Res       Date:  2011-11-28       Impact factor: 3.252

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.